Use of a lung function screening device for identifying patients at risk for COPD in general practice;COPD-Screening in der hausärztlichen Praxis mit einem Lungenfunktions-Schnellmessgerät

Pneumologie

Volumn 66, Issue 11, 2012, Pages 645-649

  Muller M ^a   Kogler H ^b   Glaab, T ^b   Welte, T ^c  

^a PFIZER INC   (United States)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BRONCHODILATING AGENT; GLUCOCORTICOID;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COUGHING; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; GENERAL PRACTICE; GENERAL PRACTITIONER; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE; PRIORITY JOURNAL; QUESTIONNAIRE; SMOKING; SPIROMETRY;

EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; FEMALE; GENERAL PRACTICE; GERMANY; HUMANS; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SPIROMETRY;

EID: 84868335713     PISSN: 09348387     EISSN: 14388790     Source Type: Journal    
DOI: 10.1055/s-0032-1325791     Document Type: Article

References (12)

1. World Health Organization Global Burden of Disease (GBD) 2005 Study. www.who.int
2. Pritzkuleit R., Beske F., Katalinic A. Erkrankungszahlen in der Pneumologie - eine Projektion bis 2060. Pneumologie: 2010; 64 535 540
3. Global Initiative for Chronic Obstructive Lung Disease Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2011; www.goldcopd.org
4. Vogelmeier C., Buhl R., Criée C. P. et al. Leitlinie der Deutschen Atemwegsliga und der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin zur Diagnostik und Therapie von Patienten mit chronisch obstruktiver Bronchitis und Lungenemphysem (COPD). Pneumologie: 2007; 61 e1 e40
5. Geldmacher H., Biller H., Herbst H. et al. Die Prävalenz der chronisch obstruktiven Lungenerkrankung (COPD) in Deutschland. Ergebnisse der BOLD-Studie. Dtsch Med Wochenschr: 2008; 133 2609 2614
6. Enright P. The use and abuse of office spirometry. Primary Care Respiratory Journal: 2008; 17 238 242
7. Frith P., Crockett A., Beilby J. et al. Simplified COPD screening: validation of the PiKo-6® in primary care. Prim Care Respir J: 2011; 20 190 198
8. Sichletidis L., Spyratos D., Papaioannou M. et al. A combination of the IPAG questionnaire and PiKo-6® flow meter is a valuable screening tool for COPD in the primary care setting. Prim Care Respir J: 2011; 20 184 189
9. Thorn J., Tilling B., Lisspers K. et al. Improved prediction of COPD in at-risk patients using lung function pre-screening in primary care: a real-life study and cost-effectiveness analysis. Prim Care Respir J: 2012; 21 159 166
10. Pedersen O. F. FEV6: a shortcut in spirometry? Eur Respir J: 2006; 27 245 247
11. 6 Eur Respir J: 2006; 27 378 383 (Pubitemid 43180918)
12. Koegler H., Metzdorf N., Glaab T. et al. Preselection of patients at risk for COPD by two simple screening questions. Respiratory Medicine: 2010; 104 1012 1019